Osteoarthritis Therapeutics Market to Reach $13.21 Billion by 2030 at 8.2% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Osteoarthritis Therapeutics Market Between 2026 And 2030?

The osteoarthritis therapeutics market has experienced substantial growth in recent years. It is projected to increase from $8.87 billion in 2025 to $9.63 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.6%. This historical expansion can be attributed to the rising prevalence of osteoarthritis, the aging global population, widespread use of NSAIDs and analgesics, the expansion of orthopedic care services, and the availability of established pain management therapies.

The osteoarthritis therapeutics market size is projected to experience substantial growth over the coming years. This market is anticipated to reach a valuation of $13.21 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.2%. Factors contributing to this growth during the forecast period include the increasing development of DMOADs, growing demand for minimally invasive therapies, the expansion of biologic and cell-based treatments, a heightened focus on personalized osteoarthritis care, and increased investment in joint disease research. Key trends expected during the forecast period encompass the increasing adoption of disease-modifying osteoarthritis therapies, a rising utilization of regenerative medicine approaches, an expanding focus on non-opioid pain management, the proliferation of injectable and intra-articular treatments, and an enhanced emphasis on early disease intervention.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19634&type=smp

Which Strong Drivers Are Impacting The Osteoarthritis Therapeutics Market Growth?

An anticipated increase in sports-related injuries is projected to fuel the expansion of the osteoarthritis therapeutics market. A sports injury is defined as any harm or damage sustained during athletic or sports participation. Such injuries vary in intensity, from minor to serious, and can impact diverse areas of the body. The uptick in sports injuries primarily stems from greater involvement in sports and the heightened intensity and competitive nature of these pursuits. In cases of sports injuries involving joint degeneration, osteoarthritis therapeutics are employed to alleviate pain and inflammation, as well as to enhance joint functionality in athletes. For example, data from July 2025, released by the Australian Institute of Health and Welfare, an Australian government body, indicated that approximately 62,100 sports injuries resulted in hospital admissions across Australia during 2023–24. Furthermore, males comprised 70% of these hospitalizations (equaling 43,800 instances), whereas females made up close to 30% (or 18,300 instances). Consequently, the increasing prevalence of sports injuries is a significant impetus behind the growth of the osteoarthritis therapeutics market.

What Are The Different Segment Types In The Osteoarthritis Therapeutics Market Segment Breakdown?

The osteoarthritis therapeutics market covered in this report is segmented –

1) By Drug Type: Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids

2) By Anatomy: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Other Anatomies

3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route

4) By Sales Channel: Prescription Drugs, Over-the-Counter Drugs

5) By End-use: Hospital Pharmacies, Retail Pharmacies, Other End-Uses

Subsegments:

1) By Viscosupplementation Agents: Hyaluronic Acid Injections, Single-Injection Products, Multi-Injection Products

2) By Nonsteroidal Anti-inflammatory Drugs: Oral NSAIDs, Topical NSAIDs, COX-2 Inhibitors

3) By Analgesics: Non-Opioid Analgesics, Topical Analgesics

4) By Corticosteroids: Injectable Corticosteroids, Intra-Articular Corticosteroids

Which Trends Are Contributing To Changes In The Osteoarthritis Therapeutics Market?

Major companies in the osteoarthritis therapeutics market are concentrating on developing innovative solutions, such as new advancements for tissue regeneration in osteoarthritis. Tissue regeneration in osteoarthritis refers to the process of mending or replacing damaged cartilage and joint tissues to restore normal function and alleviate discomfort. For instance, in May 2023, the Advanced Research Projects Agency for Health (ARPA-H), a US-based government agency, introduced the Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO). This Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program, initiated by ARPA-H, focuses on creating advanced injectable therapies that stimulate cartilage repair by leveraging biological pathways similar to those active during embryonic development. Key features include a collaborative, multimodal strategy among research teams and sophisticated testing techniques such as “joint-on-a-chip” platforms to emulate joint environments, with the aim of developing regenerative solutions that address the underlying causes of osteoarthritis.

Who Are The Well-Known Companies In The Osteoarthritis Therapeutics Market?

Major companies operating in the osteoarthritis therapeutics market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Taisho Pharmaceutical Co. Ltd., Ferring Pharmaceuticals, Bioventus LLC, Flexion Therapeutics Inc., Anika Therapeutics Inc., Seikagaku Corporation, Galapagos NV, Regeneron Pharmaceuticals Inc., Samumed LLC, Kolon Life Science Inc., Horizon Therapeutics plc

Get The Full Osteoarthritis Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/osteoarthritis-therapeutics-global-market-report

Which Region Holds The Highest Market Share In The Osteoarthritis Therapeutics Market?

North America was the largest region in the osteoarthritis therapeutics market in 2025. The regions covered in the osteoarthritis therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Osteoarthritis Therapeutics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/osteoarthritis-therapeutics-global-market-report

Browse Through More Reports Similar to the Global Osteoarthritis Therapeutics Market 2026, By The Business Research Company

Axial Spondyloarthritis Axspa Market Report 2026

https://www.thebusinessresearchcompany.com/report/axial-spondyloarthritis-axspa-global-market-report

Gouty Arthritis Market Report

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Osteoporosis Drugs Market Report

https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795